Aetna Inc. (AET) Position Increased by Dai Ichi Life Insurance Company Ltd

Dai Ichi Life Insurance Company Ltd increased its stake in Aetna Inc. (NYSE:AET) by 45.0% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 27,918 shares of the company’s stock after purchasing an additional 8,666 shares during the period. Dai Ichi Life Insurance Company Ltd’s holdings in Aetna were worth $4,239,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently added to or reduced their stakes in the company. Guardian Life Insurance Co. of America raised its position in Aetna by 0.7% during the 1st quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock worth $173,000 after buying an additional 9 shares during the last quarter. Concert Wealth Management Inc. raised its position in Aetna by 0.4% during the 1st quarter. Concert Wealth Management Inc. now owns 3,262 shares of the company’s stock worth $405,000 after buying an additional 14 shares during the last quarter. JNBA Financial Advisors raised its position in Aetna by 0.7% during the 1st quarter. JNBA Financial Advisors now owns 3,726 shares of the company’s stock worth $475,000 after buying an additional 27 shares during the last quarter. Financial Architects Inc raised its position in Aetna by 1.8% during the 2nd quarter. Financial Architects Inc now owns 1,746 shares of the company’s stock worth $265,000 after buying an additional 31 shares during the last quarter. Finally, Wedbush Securities Inc. raised its position in Aetna by 1.4% during the 2nd quarter. Wedbush Securities Inc. now owns 3,779 shares of the company’s stock worth $574,000 after buying an additional 52 shares during the last quarter. Institutional investors own 89.58% of the company’s stock.

Shares of Aetna Inc. (NYSE AET) opened at 163.21 on Tuesday. The company has a 50-day moving average of $156.27 and a 200-day moving average of $144.19. Aetna Inc. has a 1-year low of $104.59 and a 1-year high of $164.05. The firm has a market cap of $54.20 billion, a PE ratio of 36.23 and a beta of 0.53.

Aetna (NYSE:AET) last released its quarterly earnings data on Thursday, August 3rd. The company reported $3.42 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.34 by $1.08. The firm had revenue of $15.52 billion during the quarter, compared to analysts’ expectations of $15.34 billion. Aetna had a return on equity of 20.52% and a net margin of 2.52%. Aetna’s revenue was down 2.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.21 earnings per share. Analysts predict that Aetna Inc. will post $9.54 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This story was reported by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this story on another website, it was stolen and reposted in violation of international trademark & copyright laws. The legal version of this story can be accessed at https://sportsperspectives.com/2017/09/12/aetna-inc-aet-position-increased-by-dai-ichi-life-insurance-company-ltd.html.

A number of equities analysts have issued reports on AET shares. Stifel Nicolaus raised their price target on shares of Aetna from $150.00 to $158.00 and gave the stock a “buy” rating in a research report on Tuesday, May 16th. Royal Bank Of Canada raised their price target on shares of Aetna from $147.00 to $162.00 and gave the stock an “outperform” rating in a research report on Friday, June 9th. BidaskClub lowered shares of Aetna from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Deutsche Bank AG raised their price target on shares of Aetna from $157.00 to $163.00 and gave the stock a “hold” rating in a research report on Monday, August 7th. Finally, UBS AG reissued a “buy” rating and set a $160.00 price target (up from $147.00) on shares of Aetna in a research report on Wednesday, May 17th. Seven research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $157.99.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply